Netabolics
Netabolics is an award-winning AI-driven biotech startup based in Rome, Italy, focused on transforming pharmaceutical R&D through biosimulation. Their platform uses AI and mechanistic ODE models, combined with deep reinforcement learning, to simulate cellular biology and predict drug effects. This enables de-risking drug discovery by identifying and validating biological targets, predicting efficacy and toxicity, and optimizing drug profiles, leading to faster and more cost-effective development of new medicines. The company emphasizes outcome-driven and customized simulations tailored to specific project needs, aiming to accelerate the discovery of novel combination therapies, particularly in oncology.
Netabolics
Netabolics is an award-winning AI-driven biotech startup based in Rome, Italy, focused on transforming pharmaceutical R&D through biosimulation. Their platform uses AI and mechanistic ODE models, combined with deep reinforcement learning, to simulate cellular biology and predict drug effects. This enables de-risking drug discovery by identifying and validating biological targets, predicting efficacy and toxicity, and optimizing drug profiles, leading to faster and more cost-effective development of new medicines. The company emphasizes outcome-driven and customized simulations tailored to specific project needs, aiming to accelerate the discovery of novel combination therapies, particularly in oncology.